Active Ingredient(s): Naratriptan
FDA Approved: * February 10, 1998
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Amerge Overview

Naratriptan (trade names include Amerge) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT1 receptor subtype agonist. It was patented in 1987 and approved for medical use in 1997.[1] Contents 1 Medical uses 1.1 Efficacy 2 Side effects 3 Mechanism of action 4 Society and culture 5 References Medical uses Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migrai...

Read more Amerge Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Amerge Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 1mg, 2.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Amerge: (2 results)

Sorted by National Drug Code
  • 0173-0561 Amerge 1 mg Oral Tablet by Glaxosmithkline LLC
  • 0173-0562 Amerge 2.5 mg Oral Tablet by Glaxosmithkline LLC

Other drugs which contain Naratriptan or a similar ingredient: (1 result)